Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 10.86B | 11.65B | 12.16B | 13.54B | 14.31B | 13.45B |
Gross Profit | 10.86B | 11.65B | 11.47B | 13.54B | 14.31B | 13.45B |
EBITDA | 1.23B | 1.14B | 1.62B | 1.06B | 1.21B | 1.50B |
Net Income | 1.44B | 1.07B | 1.10B | 525.00M | 626.60M | 707.40M |
Balance Sheet | ||||||
Total Assets | 84.92B | 83.42B | 79.46B | 74.54B | 80.26B | 79.41B |
Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.71B | 1.82B | 43.66B | 52.63B | 53.60B |
Total Debt | 4.40B | 6.50B | 5.02B | 4.61B | 4.28B | 5.22B |
Total Liabilities | 75.23B | 73.80B | 69.66B | 66.88B | 70.54B | 69.88B |
Stockholders Equity | 9.42B | 9.37B | 8.20B | 6.13B | 7.78B | 7.61B |
Cash Flow | ||||||
Free Cash Flow | 2.69B | 1.59B | 244.00M | 1.12B | 1.41B | 503.10M |
Operating Cash Flow | 3.36B | 2.52B | 1.54B | 1.94B | 1.64B | 708.20M |
Investing Cash Flow | -3.99B | -2.77B | -1.41B | -2.12B | 594.80M | -1.80B |
Financing Cash Flow | -2.51B | 146.00M | -111.00M | 40.10M | -1.39B | 1.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $98.38B | 9.38 | 16.29% | 3.80% | 3.38% | 12.17% | |
70 Outperform | €5.46B | 13.95 | 32.52% | 5.68% | 6.75% | 0.27% | |
69 Neutral | €13.44B | 11.56 | 13.26% | 4.52% | 6.59% | -2.80% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | €50.39B | 13.09 | 13.09% | 4.32% | -0.59% | 9.24% | |
66 Neutral | €22.22B | 5.47 | 15.13% | 11.74% | -5.31% | -35.03% | |
61 Neutral | €97.87B | 10.82 | 15.91% | 6.15% | -5.85% | 15.20% |